Zhou J, Olcese R, Qin N, Noceti F, Birnbaumer L, Stefani E
Department of Anesthesiology, School of Medicine, University of California at Los Angeles, 90095-1778, USA.
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2301-5. doi: 10.1073/pnas.94.6.2301.
alpha(1C)- and alpha(1E)-based Ca2+ channels differ in that the former are inhibited by Ca2+ entering through its pore, while the latter are not. It has been proposed on the basis of analysis of alpha(1E)/alpha(1C) chimeras that the molecular determinants responsible for Ca2+ inhibition involve both a conserved Ca2+-binding motif (EF hand) plus additional sequences located C-terminal to the EF hand. Through construction of similar alpha(1E)/alpha(1C) chimeras, we transferred Ca2+ inhibition from alpha(1C) to alpha(1E) by replacing a 134-aa segment of alpha(1E) with the homologous 142-aa segment of alpha(1C). This segment is located immediately after the proposed Ca2+ -binding EF hand motif. Replacement of the alpha(1C) EF hand with the corresponding EF hand of alpha(1E) did not interfere with inhibition of alpha(1C) by Ca2+, and a triple mutant of alpha(1C), alpha(1C)[D1535A,E1537A,D1546A], that disrupts the potential Ca2+-coordinating ability of the EF hand continued to be inhibited by Ca2+. These results indicate that a small portion of the alpha(1C) C terminus is essential for inhibition by Ca2+ and place the Ca2+ -binding site anywhere in alpha(1C), with the exception of its EF hand-like motif.
基于α(1C)和α(1E)的钙离子通道的不同之处在于,前者会被通过其孔道进入的钙离子所抑制,而后者则不会。基于对α(1E)/α(1C)嵌合体的分析,有人提出负责钙离子抑制的分子决定因素既包括一个保守的钙离子结合基序(EF手),也包括位于EF手C末端的其他序列。通过构建类似的α(1E)/α(1C)嵌合体,我们将α(1C)的钙离子抑制作用转移到了α(1E)上,方法是用α(1C)的同源142个氨基酸片段替换α(1E)的134个氨基酸片段。该片段紧接在提议的钙离子结合EF手基序之后。用α(1E)的相应EF手替换α(1C)的EF手并不干扰钙离子对α(1C)的抑制作用,并且α(1C)的一个三重突变体α(1C)[D1535A,E1537A,D1546A],它破坏了EF手潜在的钙离子配位能力,仍然会被钙离子抑制。这些结果表明,α(1C) C末端的一小部分对于钙离子抑制至关重要,并将钙离子结合位点定位在α(1C)中的任何位置,但不包括其EF手样基序。